Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma

Leukemia

Volumn 12, Issue 8, 1998, Pages 1277-1280

  Nakahara, Y ^a   Nagai, H ^a   Kinoshita, T ^a   Uchida, T ^a   Hatano, S ^a   Murate, T ^a   Saito, H ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chromosome 10q23.3; Mutation; Non Hodgkin's lymphoma; Phosphatase; PTEN MMAC1 gene

Indexed keywords

MESSENGER RNA; PHOSPHATASE;

ARTICLE; B CELL LYMPHOMA; CHROMOSOME 10Q; CLINICAL ARTICLE; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; GENOME; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031855499     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401099     Document Type: Article

References (23)

1. Offit K, Wong G, Fillippa DA, Tao Y, Chaganti RSK. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991; 77: 1508-1515.
2. Rowley JD. Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 1990; 27: 122-136.
3. Motokura T, Bloom T, Kim HG, Juppener H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991; 350: 512-515.
4. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443.
5. Baron BW, Nucifora G, MacCabe N, Espinosa R III, LeBeau MM, McKeithan TW. Identification of the gene associated with recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q32;q11) in B cell lymphomas. Proc Natl Acad Sci USA 1993; 90: 5262-5266.
6. Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K, Saito H. Mutations of p53 gene and their relation to disease progression in B cell lymphoma. Blood 1992; 79: 2701-2707.
7. INK4A) gene in primary B cell lymphomas. Blood 1995; 86: 2724-2731.
8. Ichikawa T, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K, Saito H, Hotta T. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. New Engl J Med 1997; 337: 529-534.
9. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
10. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hatter T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancer. Nat Genet 1997; 15: 356-362.
11. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997; 57: 4183-4186.
12. Guldberg P, Thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997; 57: 3660-3663.
13. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997; 57: 3935-3940.
14. Rhei E, Kang R, Bogomolniy F, Federici MG, Borgen PI, Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 1997; 57: 3657-3659.
15. Nelson MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Marimann EC, Padberg GW, Kremer H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997; 6: 1383-1387.
16. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 1997; 94: 9052-9057.
17. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Mannual. Cold Spring Harbor, Laboratory: Cold Spring Harbor, NY, 1992.
18. Orita M, Iwahana H, Kanazawa K, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770.
19. Nagai H, Kinoshita T, Imamura J, Murakami Y, Hayashi K, Mukai K, Ikeda S, Tobinai K, Saito H, Shimoyama M, Shimotohno K. Genetic alteration of p53 in some patients with adult T cell leukemia. Jpn J Cancer Res 1991; 82: 1421-1427.
20. Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM. Detection and cloning of common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res 1995; 55: 1752-1757.
21. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-8148.
22. LaForgia S, Morse B, Levy J, Barnea G, Cannizzaro LA, Nowell PC, Boghosian-Sell L, Glick J, Weston A, Harris CC, Drabkin H, Patterson D, Croce CM, Schlessinger J, Huebner K. Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA 1991; 88: 5036-5040.
23. Hunter T. The functions of oncogene products. Prog Clin Biol Res 1989; 288: 25-34.